BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, Sutton IJ, Xin C, Tangye SG, Kalled SL, Mackay F, Mackay CR. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004;173:807-817. [PMID: 15240667 DOI: 10.4049/jimmunol.173.2.807] [Cited by in Crossref: 339] [Cited by in F6Publishing: 315] [Article Influence: 19.9] [Reference Citation Analysis]
Number Citing Articles
1 Lugade AA, Vethanayagam RR, Nasirikenari M, Bogner PN, Segal BH, Thanavala Y. Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae. Am J Respir Cell Mol Biol 2011;45:557-65. [PMID: 21216970 DOI: 10.1165/rcmb.2010-0321OC] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
2 Jacob CO, Pricop L, Putterman C, Koss MN, Liu Y, Kollaros M, Bixler SA, Ambrose CM, Scott ML, Stohl W. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 2006;177:2671-80. [PMID: 16888029 DOI: 10.4049/jimmunol.177.4.2671] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
3 Sun L, Zhou L, Chen M, Zhong R, Liu J. Amelioration of systemic lupus erythematosus by Withangulatin A in MRL/lpr mice. J Cell Biochem 2011;112:2376-82. [PMID: 21520246 DOI: 10.1002/jcb.23160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ. Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Res Ther 2015;17:215. [PMID: 26290435 DOI: 10.1186/s13075-015-0741-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
5 Gor DO, Ding X, Li Q, Sultana D, Mambula SS, Bram RJ, Greenspan NS. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS). Biol Direct 2011;6:9. [PMID: 21306646 DOI: 10.1186/1745-6150-6-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Saito Y, Miyagawa Y, Onda K, Nakajima H, Sato B, Horiuchi Y, Okita H, Katagiri YU, Saito M, Shimizu T, Fujimoto J, Kiyokawa N. B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells. Immunology 2008;125:570-90. [PMID: 18540961 DOI: 10.1111/j.1365-2567.2008.02872.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
7 Elgueta R, de Vries VC, Noelle RJ. The immortality of humoral immunity. Immunol Rev 2010;236:139-50. [PMID: 20636814 DOI: 10.1111/j.1600-065X.2010.00924.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
8 Ramanujam M, Wang X, Huang W, Liu Z, Schiffer L, Tao H, Frank D, Rice J, Diamond B, Yu KO, Porcelli S, Davidson A. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest 2006;116:724-34. [PMID: 16485042 DOI: 10.1172/JCI26385] [Cited by in Crossref: 157] [Cited by in F6Publishing: 85] [Article Influence: 10.5] [Reference Citation Analysis]
9 Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol 2006;18:284-9. [PMID: 16931039 DOI: 10.1016/j.smim.2006.04.005] [Cited by in Crossref: 124] [Cited by in F6Publishing: 98] [Article Influence: 8.3] [Reference Citation Analysis]
10 Wang Q, He F, He W, Huang Y, Zeng J, Zi F, Zheng J, Fei Y, Xu J, Song Y, Ye X, Lai R, Ye L, Zhu B. A transgene-encoded truncated human epidermal growth factor receptor for depletion of anti- B-cell maturation antigen CAR-T cells. Cell Immunol 2021;363:104342. [PMID: 33765541 DOI: 10.1016/j.cellimm.2021.104342] [Reference Citation Analysis]
11 Pranzatelli MR, Tate ED, Travelstead AL, Verhulst SJ. Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS. Cytokine 2011;53:384-9. [DOI: 10.1016/j.cyto.2010.12.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
12 Chong BF, Tseng LC, Kim A, Miller RT, Yancey KB, Hosler GA. Differential expression of BAFF and its receptors in discoid lupus erythematosus patients. J Dermatol Sci 2014;73:216-24. [PMID: 24315762 DOI: 10.1016/j.jdermsci.2013.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
13 Ragheb S, Li Y, Simon K, VanHaerents S, Galimberti D, De Riz M, Fenoglio C, Scarpini E, Lisak R. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. Mult Scler 2011;17:819-29. [PMID: 21372118 DOI: 10.1177/1352458511398887] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
14 Ng LG, Ng CH, Woehl B, Sutherland AP, Huo J, Xu S, Mackay F, Lam KP. BAFF costimulation of Toll-like receptor-activated B-1 cells. Eur J Immunol 2006;36:1837-46. [PMID: 16791880 DOI: 10.1002/eji.200635956] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
15 Nakajima K, Itoh K, Nagatani K, Okawa-Takatsuji M, Fujii T, Kuroki H, Katsuragawa Y, Aotsuka S, Mimori A. Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. Scand J Rheumatol 2007;36:365-72. [PMID: 17963166 DOI: 10.1080/03009740701286615] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
16 Yu C, Chen S, Zhou B, Zhang H, Su X, Luo Y, Yang L. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice. Mol Immunol 2021;129:1-11. [PMID: 33254074 DOI: 10.1016/j.molimm.2020.11.010] [Reference Citation Analysis]
17 Salzer U, Jennings S, Grimbacher B. To switch or not to switch--the opposing roles of TACI in terminal B cell differentiation. Eur J Immunol 2007;37:17-20. [PMID: 17171762 DOI: 10.1002/eji.200636914] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
18 Piantoni S, Regola F, Masneri S, Merletti M, Lowin T, Airò P, Tincani A, Franceschini F, Andreoli L, Pongratz G. Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. Front Pharmacol 2021;12:666971. [PMID: 34093196 DOI: 10.3389/fphar.2021.666971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Samoud-El Kissi S, Galai Y, Sghiri R, Kenani N, Ben Alaya-Bouafif N, Boukadida J, Denguezli M, Nouira R, Louzir H. BAFF is elevated in serum of patients with psoriasis: association with disease activity. Br J Dermatol 2008;159:765-8. [PMID: 18637006 DOI: 10.1111/j.1365-2133.2008.08737.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
20 Ettinger R, Sims GP, Robbins R, Withers D, Fischer RT, Grammer AC, Kuchen S, Lipsky PE. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol 2007;178:2872-82. [PMID: 17312131 DOI: 10.4049/jimmunol.178.5.2872] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 7.6] [Reference Citation Analysis]
21 Mariño E, Walters SN, Villanueva JE, Richards JL, Mackay CR, Grey ST. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Eur J Immunol 2014;44:983-93. [PMID: 24435807 DOI: 10.1002/eji.201344186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
22 Berrih-aknin S, Ragheb S, Le Panse R, Lisak RP. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmunity Reviews 2013;12:885-93. [DOI: 10.1016/j.autrev.2013.03.011] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
23 Smulski CR, Eibel H. BAFF and BAFF-Receptor in B Cell Selection and Survival. Front Immunol. 2018;9:2285. [PMID: 30349534 DOI: 10.3389/fimmu.2018.02285] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 23.3] [Reference Citation Analysis]
24 Wada K, Maeda K, Tajima K, Kato T, Kobata T, Yamakawa M. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology 2009;54:221-32. [DOI: 10.1111/j.1365-2559.2008.03203.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
25 Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome. Scand J Immunol 2005;62:421-8. [PMID: 16305638 DOI: 10.1111/j.1365-3083.2005.01688.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
26 Kullberg S, Rivera NV, Grunewald J, Eklund A. Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis. BMJ Open Respir Res 2021;8:e000933. [PMID: 34233893 DOI: 10.1136/bmjresp-2021-000933] [Reference Citation Analysis]
27 Manetta J, Bina H, Ryan P, Fox N, Witcher DR, Kikly K. Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor. J Inflamm Res 2014;7:121-31. [PMID: 25258549 DOI: 10.2147/JIR.S67751] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
28 Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, Ettinger R. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 2007;179:5886-96. [PMID: 17947662 DOI: 10.4049/jimmunol.179.9.5886] [Cited by in Crossref: 202] [Cited by in F6Publishing: 193] [Article Influence: 14.4] [Reference Citation Analysis]
29 Thangarajh M, Masterman T, Helgeland L, Rot U, Jonsson MV, Eide GE, Pirskanen R, Hillert J, Jonsson R. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis. J Neuroimmunol 2006;178:161-6. [PMID: 16820216 DOI: 10.1016/j.jneuroim.2006.05.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
30 Baek A, Park HJ, Na S, Shim DS, Moon J, Yang Y, Choi Y. The expression of BAFF in the muscles of patients with dermatomyositis. Journal of Neuroimmunology 2012;249:96-100. [DOI: 10.1016/j.jneuroim.2012.04.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
31 Thibault-Espitia A, Foucher Y, Danger R, Migone T, Pallier A, Castagnet S, G-Gueguen C, Devys A, C-Gautier A, Giral M. BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant. 2012;12:2754-2762. [PMID: 22883025 DOI: 10.1111/j.1600-6143.2012.04194.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
32 Ferrer G, Hodgson K, Montserrat E, Moreno C. B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity. Leukemia & Lymphoma 2009;50:1075-82. [DOI: 10.1080/10428190903013334] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
33 Stefanich EG, Ren S, Danilenko DM, Lim A, Song A, Iyer S, Fielder PJ. Evidence for an asialoglycoprotein receptor on nonparenchymal cells for O-linked glycoproteins. J Pharmacol Exp Ther 2008;327:308-15. [PMID: 18728239 DOI: 10.1124/jpet.108.142232] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
34 Sathkumara HD, De Silva NR, Handunnetti S, De Silva AD. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor. Int J Immunogenet 2015;42:239-53. [DOI: 10.1111/iji.12217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
35 Mackay F, Figgett WA, Saulep D, Lepage M, Hibbs ML. B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor: BAFF and BCR-mediated B-cell survival. Immunological Reviews 2010;237:205-25. [DOI: 10.1111/j.1600-065x.2010.00944.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 81] [Article Influence: 11.5] [Reference Citation Analysis]
36 Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. Blood 2016;128:1688-700. [PMID: 27412889 DOI: 10.1182/blood-2016-04-711903] [Cited by in Crossref: 396] [Cited by in F6Publishing: 349] [Article Influence: 79.2] [Reference Citation Analysis]
37 Liu D, Li P, Song S, Liu Y, Wang Q, Chang Y, Wu Y, Chen J, Zhao W, Zhang L, Wei W. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis. Eur J Pharmacol 2012;690:214-25. [PMID: 22760071 DOI: 10.1016/j.ejphar.2012.06.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
38 Bruzova M, Pavlova M, Matej R, Sterclova M, Vasakova M. Interstitial Score and Concentrations of IL-4Rα, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias. Diagnostics (Basel) 2021;11:693. [PMID: 33924683 DOI: 10.3390/diagnostics11040693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tafalla C, Granja AG. Novel Insights on the Regulation of B Cell Functionality by Members of the Tumor Necrosis Factor Superfamily in Jawed Fish. Front Immunol 2018;9:1285. [PMID: 29930556 DOI: 10.3389/fimmu.2018.01285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
40 Zhang T, Sun J, Cheng J, Yin W, Li J, Miller H, Herrada AA, Gu H, Song H, Chen Y, Gong Q, Liu C. The role of ubiquitinase in B cell development and function. J Leukoc Biol 2021;109:395-405. [PMID: 32816356 DOI: 10.1002/JLB.1MR0720-185RR] [Reference Citation Analysis]
41 Lee JW, Lee J, Um SH, Moon EY. Synovial cell death is regulated by TNF-α-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1α. Cell Death Dis 2017;8:e2727. [PMID: 28383556 DOI: 10.1038/cddis.2017.26] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
42 Lee JJ, Ozcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 2008;8:520-6. [PMID: 18978466 DOI: 10.1097/ACI.0b013e3283141200] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
43 Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Böhm J, Kienzler AK, Pan-Hammarström Q, Hammarström L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009;106:13945-50. [PMID: 19666484 DOI: 10.1073/pnas.0903543106] [Cited by in Crossref: 250] [Cited by in F6Publishing: 213] [Article Influence: 20.8] [Reference Citation Analysis]
44 Valenzuela NM. IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype. Front Immunol 2021;12:648946. [PMID: 33936069 DOI: 10.3389/fimmu.2021.648946] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Mackay F, Schneider P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev 2008;19:263-76. [PMID: 18514565 DOI: 10.1016/j.cytogfr.2008.04.006] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 7.3] [Reference Citation Analysis]
46 Jacob CO, Guo S, Jacob N, Pawar RD, Putterman C, Quinn WJ 3rd, Cancro MP, Migone TS, Stohl W. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice. Arthritis Rheum 2012;64:1610-9. [PMID: 22127792 DOI: 10.1002/art.33458] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
47 Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol. 2017;36:3-19. [PMID: 28215100 DOI: 10.1080/08830185.2016.1276903] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 15.8] [Reference Citation Analysis]
48 Sundström M, Lejon K. Idd-linked genetic regulation of TACIhigh expressing B cells in NOD mice. J Autoimmun 2007;29:116-24. [PMID: 17656068 DOI: 10.1016/j.jaut.2007.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Kanswal S, Katsenelson N, Selvapandiyan A, Bram RJ, Akkoyunlu M. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL. J Immunol 2008;181:976-90. [PMID: 18606649 DOI: 10.4049/jimmunol.181.2.976] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
50 Regola F, Piantoni S, Lowin T, Archetti S, Reggia R, Kumar R, Franceschini F, Airò P, Tincani A, Andreoli L, Pongratz G. Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab. Front Pharmacol 2019;10:433. [PMID: 31105569 DOI: 10.3389/fphar.2019.00433] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
51 Zheng Y, Gallucci S, Gaughan JP, Gross JA, Monestier M. A role for B cell-activating factor of the TNF family in chemically induced autoimmunity. J Immunol 2005;175:6163-8. [PMID: 16237113 DOI: 10.4049/jimmunol.175.9.6163] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
52 Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN. T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. J Clin Oncol 2018;36:2267-80. [PMID: 29812997 DOI: 10.1200/JCO.2018.77.8084] [Cited by in Crossref: 289] [Cited by in F6Publishing: 165] [Article Influence: 96.3] [Reference Citation Analysis]
53 Ejaz NS, Shields AR, Alloway RR, Sadaka B, Girnita AL, Mogilishetty G, Cardi M, Woodle ES. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant 2013;13:3142-54. [PMID: 24266968 DOI: 10.1111/ajt.12493] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
54 Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011;1246:41-9. [PMID: 22236429 DOI: 10.1111/j.1749-6632.2011.06338.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
55 Smets I, Prezzemolo T, Imbrechts M, Mallants K, Mitera T, Humblet-Baron S, Dubois B, Matthys P, Liston A, Goris A. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis. Front Immunol 2021;12:676619. [PMID: 34122439 DOI: 10.3389/fimmu.2021.676619] [Reference Citation Analysis]
56 Liu J, Clayton K, Gao W, Li Y, Zealey C, Budylowski P, Schwartz J, Yue FY, Bie Y, Rini J, Ostrowski M. Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice. Vaccine 2020;38:2149-59. [PMID: 32014267 DOI: 10.1016/j.vaccine.2020.01.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
57 Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, Rolph MS, Mackay F, Mackay CR. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005;174:5537-44. [PMID: 15843552 DOI: 10.4049/jimmunol.174.9.5537] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
58 La Cava A. Targeting the BLyS-APRIL signaling pathway in SLE. Clin Immunol 2013;148:322-7. [PMID: 23269199 DOI: 10.1016/j.clim.2012.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
59 Ma L, Li R, Huang H, Yuan J, Ou S, Xu T, Yu X, Liu X, Chen Y. Up-regulated BAFF and BAFF receptor expression in patients with intractable temporal lobe epilepsy and a pilocarpine-induced epilepsy rat model. Seizure 2017;48:79-88. [DOI: 10.1016/j.seizure.2017.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Crowley JE, Treml LS, Stadanlick JE, Carpenter E, Cancro MP. Homeostatic niche specification among naïve and activated B cells: A growing role for the BLyS family of receptors and ligands. Seminars in Immunology 2005;17:193-9. [DOI: 10.1016/j.smim.2005.02.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
61 Tertilt C, Joh J, Krause A, Chou P, Schneeweiss K, Crystal RG, Worgall S. Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa. Infect Immun 2009;77:3044-55. [PMID: 19364838 DOI: 10.1128/IAI.00927-08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
62 Degner KR, Wilson NA, Reese SR, Parajuli S, Aziz F, Garg N, Mohamed M, Singh T, Mandelbrot DA, Panzer SE, Redfield RR, Van Hyfte K, Zhong W, Hidalgo LG, Djamali A. Short-term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection. Kidney360 2020;1:389-98. [PMID: 34476406 DOI: 10.34067/kid.0001082019] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Zhang M, Ko KH, Lam QL, Lo CK, Srivastava G, Zheng B, Lau YL, Lu L. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol 2005;17:1081-92. [PMID: 16000326 DOI: 10.1093/intimm/dxh287] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
64 Song J, Lokmic Z, Lämmermann T, Rolf J, Wu C, Zhang X, Hallmann R, Hannocks MJ, Horn N, Ruegg MA. Extracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival. Proc Natl Acad Sci USA. 2013;110:E2915-E2924. [PMID: 23847204 DOI: 10.1073/pnas.1218131110] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
65 Huard B, McKee T, Bosshard C, Durual S, Matthes T, Myit S, Donze O, Frossard C, Chizzolini C, Favre C, Zubler R, Guyot JP, Schneider P, Roosnek E. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest 2008;118:2887-95. [PMID: 18618015 DOI: 10.1172/JCI33760] [Cited by in Crossref: 31] [Cited by in F6Publishing: 74] [Article Influence: 2.4] [Reference Citation Analysis]
66 Lee L, Draper B, Chaplin N, Philip B, Chin M, Galas-Filipowicz D, Onuoha S, Thomas S, Baldan V, Bughda R, Maciocia P, Kokalaki E, Neves MP, Patel D, Rodriguez-Justo M, Francis J, Yong K, Pule M. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood 2018;131:746-58. [PMID: 29284597 DOI: 10.1182/blood-2017-05-781351] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 18.5] [Reference Citation Analysis]
67 Li X, Xiao B, Xi J, Lu C, Lu J. Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis. Clinical Immunology 2008;126:180-8. [DOI: 10.1016/j.clim.2007.10.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
68 Migita K, Abiru S, Maeda Y, Nakamura M, Komori A, Ito M, Fujiwara S, Yano K, Yatsuhashi H, Eguchi K. Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum Immunol. 2007;68:586-591. [PMID: 17584580 DOI: 10.1016/j.humimm.2007.03.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
69 Bae J, Samur M, Richardson P, Munshi NC, Anderson KC. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy. Leukemia 2019;33:2208-26. [PMID: 30872779 DOI: 10.1038/s41375-019-0414-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
70 Cui XW, Li JF, Xiao W, Xuan Y, Tian AY, Xu XZ, Zhang SQ. Molecular cloning, expression and functional analysis of TNF13b (BAFF) in Japanese sea perch, Lateolabrax japonicus. Int Immunopharmacol 2012;12:34-41. [PMID: 22032840 DOI: 10.1016/j.intimp.2011.10.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
71 Nestorov I, Munafo A, Papasouliotis O, Visich J. Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis. J Clin Pharmacol 2008;48:406-17. [PMID: 18303125 DOI: 10.1177/0091270008315312] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
72 Yazdani R, Hakemi MG, Sherkat R, Homayouni V, Farahani R. Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency. Adv Biomed Res 2014;3:2. [PMID: 24600593 DOI: 10.4103/2277-9175.124627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
73 Xu X, Huang S, Xiao X, Sun Q, Liang X, Chen S, Zhao Z, Huo Z, Tu S, Li Y. Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments. Front Immunol 2020;11:569117. [PMID: 33643279 DOI: 10.3389/fimmu.2020.569117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Zhang B, Hu M, Zhang P, Cao H, Wang Y, Wang Z, Su T. BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis. Braz J Med Biol Res 2013;46:433-9. [PMID: 23681290 DOI: 10.1590/1414-431X20132665] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
75 Kim SS, Richman DP, Zamvil SS, Agius MA. Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice. J Neurol Sci 2011;306:9-15. [PMID: 21529843 DOI: 10.1016/j.jns.2011.04.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
76 Comarmond C, Cacoub P, Saadoun D. Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals. Therap Adv Gastroenterol. 2020;13:1756284820942617. [PMID: 32782479 DOI: 10.1177/1756284820942617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Wang H, Chen T, Ding T, Zhu P, Xu X, Yu L, Xie Y. Adipogenic differentiation alters the immunoregulatory property of mesenchymal stem cells through BAFF secretion. Hematology 2011;16:313-23. [PMID: 21902897 DOI: 10.1179/102453311X13085644679944] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
78 Kurokawa A, Yamamoto Y. Immunohistochemical identification of T and B lymphocytes in formalin-fixed paraffin-embedded chicken tissues using commercial antibodies. Vet Immunol Immunopathol 2020;228:110088. [PMID: 32688059 DOI: 10.1016/j.vetimm.2020.110088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Roosnek E, Burjanadze M, Dietrich P, Matthes T, Passweg J, Huard B. Tumors that look for their springtime in APRIL. Critical Reviews in Oncology/Hematology 2009;72:91-7. [DOI: 10.1016/j.critrevonc.2009.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
80 Salzer U, Grimbacher B. Common variable immunodeficiency: The power of co-stimulation. Seminars in Immunology 2006;18:337-46. [DOI: 10.1016/j.smim.2006.07.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
81 Magee N, Zou A, Zhang Y. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells. Biomed Res Int. 2016;2016:5170402. [PMID: 27822476 DOI: 10.1155/2016/5170402] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
82 Haley SL, Tzvetkov EP, Meuwissen S, Plummer JR, McGettigan JP. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis. J Virol 2017;91:e02435-16. [PMID: 28148792 DOI: 10.1128/JVI.02435-16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. Cancer Res 2010;70:4346-56. [PMID: 20460528 DOI: 10.1158/0008-5472.CAN-10-0300] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
84 Lee J, Yoon SS, Thuy PX, Moon EY. Synovial Cell Migration is Associated with B Cell Activating Factor Expression Increased by TNFα or Decreased by KR33426. Biomol Ther (Seoul) 2020;28:405-13. [PMID: 32753567 DOI: 10.4062/biomolther.2020.110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
85 Doycheva I, Watt KD, Gulamhusein AF. Autoimmune hepatitis: Current and future therapeutic options. Liver Int 2019;39:1002-13. [DOI: 10.1111/liv.14062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
86 Binard A, Le Pottier L, Saraux A, Devauchelle-Pensec V, Pers JO, Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus? J Autoimmun 2008;30:63-7. [PMID: 18155417 DOI: 10.1016/j.jaut.2007.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
87 Izumi K, Bieber K, Ludwig RJ. Current Clinical Trials in Pemphigus and Pemphigoid. Front Immunol 2019;10:978. [PMID: 31130959 DOI: 10.3389/fimmu.2019.00978] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
88 Pan T, Tan R, Li M, Liu Z, Wang X, Tian L, Liu J, Qu H. IL17-Producing γδ T Cells May Enhance Humoral Immunity during Pulmonary Pseudomonas aeruginosa Infection in Mice. Front Cell Infect Microbiol 2016;6:170. [PMID: 27999768 DOI: 10.3389/fcimb.2016.00170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
89 Duan B, Niu H, Xu Z, Sharpe AH, Croker BP, Sobel ES, Morel L. Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest 2008;88:1008-20. [PMID: 18607347 DOI: 10.1038/labinvest.2008.62] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
90 Kumsiri R, Potup P, Chotivanich K, Petmitr S, Kalambaheti T, Maneerat Y. Blood stage Plasmodium falciparum antigens induce T cell independent immunoglobulin production via B cell activation factor of the TNF family (BAFF) pathway. Acta Trop 2010;116:217-26. [PMID: 20804716 DOI: 10.1016/j.actatropica.2010.08.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
91 Tangye SG, Bryant VL, Cuss AK, Good KL. BAFF, APRIL and human B cell disorders. Semin Immunol 2006;18:305-17. [PMID: 16916610 DOI: 10.1016/j.smim.2006.04.004] [Cited by in Crossref: 149] [Cited by in F6Publishing: 124] [Article Influence: 9.9] [Reference Citation Analysis]
92 Scapini P, Hu Y, Chu CL, Migone TS, Defranco AL, Cassatella MA, Lowell CA. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 2010;207:1757-73. [PMID: 20624892 DOI: 10.1084/jem.20100086] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 7.6] [Reference Citation Analysis]
93 Badr G, Borhis G, Lefevre EA, Chaoul N, Deshayes F, Dessirier V, Lapree G, Tsapis A, Richard Y. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008;111:2744-54. [PMID: 18172003 DOI: 10.1182/blood-2007-03-081232] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
94 Giordano D, Draves KE, Young LB, Roe K, Bryan MA, Dresch C, Richner JM, Diamond MS, Gale M Jr, Clark EA. Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization. PLoS Pathog 2017;13:e1006743. [PMID: 29176765 DOI: 10.1371/journal.ppat.1006743] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
95 Zouali M, Uy EA. Belimumab Therapy in Systemic Lupus Erythematosus. BioDrugs 2013;27:225-35. [DOI: 10.1007/s40259-013-0031-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
96 Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai S, Compaan DM, Yin J, Gong Q, Kelley RF, Deforge LE, Martin F, Starovasnik MA, Fuh G. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 2006;108:3103-11. [DOI: 10.1182/blood-2006-03-011031] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
97 Dechkajorn W, Benjathummarak S, Kumsiri R, Maneerat Y. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin. Cytokine 2018;111:445-53. [PMID: 29884307 DOI: 10.1016/j.cyto.2018.05.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Darce JR, Arendt BK, Wu X, Jelinek DF. Regulated expression of BAFF-binding receptors during human B cell differentiation. J Immunol 2007;179:7276-86. [PMID: 18025170 DOI: 10.4049/jimmunol.179.11.7276] [Cited by in Crossref: 179] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
99 Lucas AH, Rittenhouse-Olson K, Kronenberg M, Apicella MA, Wang D, Schreiber JR, Taylor CE. Carbohydrate Moieties as Vaccine Candidates: meeting summary. Vaccine 2010;28:1121-31. [PMID: 18579261 DOI: 10.1016/j.vaccine.2008.05.055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
100 Lied GA, Berstad A. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol. 2011;73:1-7. [PMID: 21128997 DOI: 10.1111/j.1365-3083.2010.02470.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
101 Salzer U, Chapel HM, Webster AD, Pan-Hammarström Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schäffer AA. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37:820-828. [PMID: 16007087 DOI: 10.1038/ng1600] [Cited by in Crossref: 475] [Cited by in F6Publishing: 385] [Article Influence: 29.7] [Reference Citation Analysis]
102 Ryan MC, Grewal IS. Targeting of BAFF and APRIL for Autoimmunity and Oncology. In: Grewal IS, editor. Therapeutic Targets of the TNF Superfamily. New York: Springer; 2009. pp. 52-63. [DOI: 10.1007/978-0-387-89520-8_4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
103 Moura RA, Quaresma C, Vieira AR, Gonçalves MJ, Polido-Pereira J, Romão VC, Martins N, Canhão H, Fonseca JE. B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. PLoS One 2017;12:e0182927. [PMID: 28886017 DOI: 10.1371/journal.pone.0182927] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
104 Kyaw T, Tay C, Hosseini H, Kanellakis P, Gadowski T, MacKay F, Tipping P, Bobik A, Toh BH. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS One 2012;7:e29371. [PMID: 22238605 DOI: 10.1371/journal.pone.0029371] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 12.9] [Reference Citation Analysis]
105 Kuo TC, Shaffer AL, Haddad J Jr, Choi YS, Staudt LM, Calame K. Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med 2007;204:819-30. [PMID: 17403935 DOI: 10.1084/jem.20062104] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
106 Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu CM, Kalled SL, Hess DM, Serafini B, Aloisi F, Wekerle H, Hohlfeld R, Meinl E. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005;201:195-200. [PMID: 15642740 DOI: 10.1084/jem.20041674] [Cited by in Crossref: 340] [Cited by in F6Publishing: 302] [Article Influence: 21.3] [Reference Citation Analysis]
107 Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion. Eur J Immunol 2007;37:1785-95. [PMID: 17557373 DOI: 10.1002/eji.200636800] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
108 von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS. Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol 2015;73:238-46. [PMID: 25824054 DOI: 10.1159/000377675] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
109 Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 2013;24:203-15. [PMID: 23684423 DOI: 10.1016/j.cytogfr.2013.04.003] [Cited by in Crossref: 223] [Cited by in F6Publishing: 184] [Article Influence: 27.9] [Reference Citation Analysis]
110 Severa M, Islam SA, Waggoner SN, Jiang Z, Kim ND, Ryan G, Kurt-Jones E, Charo I, Caffrey DR, Boyartchuk VL, Luster AD, Fitzgerald KA. The transcriptional repressor BLIMP1 curbs host defenses by suppressing expression of the chemokine CCL8. J Immunol 2014;192:2291-304. [PMID: 24477914 DOI: 10.4049/jimmunol.1301799] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
111 Kimberley FC, Medema JP, Hahne M. APRIL in B-cell Malignancies and Autoimmunity. In: Kalthoff H, editor. Death Receptors and Cognate Ligands in Cancer. Berlin: Springer Berlin Heidelberg; 2009. pp. 161-82. [DOI: 10.1007/400_2008_19] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
112 Pylaeva E, Ozel I, Squire A, Spyra I, Wallner C, Korek M, Korschunow G, Domnich M, Siakaeva E, Goetz M, Bankfalvi A, Lang S, Kansy B, Jablonska J. B-Helper Neutrophils in Regional Lymph Nodes Correlate with Improved Prognosis in Patients with Head and Neck Cancer. Cancers (Basel) 2021;13:3092. [PMID: 34205654 DOI: 10.3390/cancers13123092] [Reference Citation Analysis]
113 Mourad W, Lipsky PE, Zouali M. B cells and autoimmunity 2004: new concepts and therapeutic perspectives. Expert Opinion on Therapeutic Targets 2005;9:195-200. [DOI: 10.1517/14728222.9.1.195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Rahmanzadeh R, Weber MS, Brück W, Navardi S, Sahraian MA. B cells in multiple sclerosis therapy-A comprehensive review. Acta Neurol Scand 2018;137:544-56. [PMID: 29512131 DOI: 10.1111/ane.12915] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
115 Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Colliver JA, Ness JM, Ransohoff RM. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. J Neuroinflammation 2013;10:10. [PMID: 23324534 DOI: 10.1186/1742-2094-10-10] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
116 Chang Y, Sun X, Jia X, Xu S, Wei F, Yang X, Wei W. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis. International Immunopharmacology 2015;24:451-7. [DOI: 10.1016/j.intimp.2015.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
117 Jin W, Luo Z, Yang H. Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies. J Immunol Res 2020;2020:9518137. [PMID: 32280720 DOI: 10.1155/2020/9518137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
118 Treml LS, Quinn WJ 3rd, Treml JF, Scholz JL, Cancro MP. Manipulating B cell homeostasis: a key component in the advancement of targeted strategies. Arch Immunol Ther Exp (Warsz) 2008;56:153-64. [PMID: 18512030 DOI: 10.1007/s00005-008-0017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
119 Mahler MR, Søndergaard HB, Buhelt S, von Essen MR, Romme Christensen J, Enevold C, Sellebjerg F. Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis. Multiple Sclerosis and Related Disorders 2020;45:102391. [DOI: 10.1016/j.msard.2020.102391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
120 Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005;42:763-72. [PMID: 15829264 DOI: 10.1016/j.molimm.2004.06.041] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
121 Thangarajh M, Kisiswa L, Pirskanen R, Hillert J. The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis. Scand J Immunol 2007;65:461-6. [PMID: 17444957 DOI: 10.1111/j.1365-3083.2007.01921.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
122 Hong C, Jin R, Dai X, Gao X. Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease. Front Immunol 2021;12:614183. [PMID: 33717098 DOI: 10.3389/fimmu.2021.614183] [Reference Citation Analysis]
123 Hendriks J, Planelles L, de Jong-Odding J, Hardenberg G, Pals ST, Hahne M, Spaargaren M, Medema JP. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005;12:637-48. [PMID: 15846369 DOI: 10.1038/sj.cdd.4401647] [Cited by in Crossref: 154] [Cited by in F6Publishing: 129] [Article Influence: 9.6] [Reference Citation Analysis]
124 Mongini PK, Inman JK, Han H, Fattah RJ, Abramson SB, Attur M. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2. J Immunol 2006;176:6736-51. [PMID: 16709833 DOI: 10.4049/jimmunol.176.11.6736] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
125 Ibtehaj N, Huda R. High-dose BAFF receptor specific mAb-siRNA conjugate generates Fas-expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse model. Clinical Immunology 2017;176:122-30. [DOI: 10.1016/j.clim.2017.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
126 Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, Jahn A, Sauleda J, Divo M, Pinto-Plata V, Sholl L, Rosas IO, Agustí A, Celli BR, Owen CA. B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2015;192:695-705. [PMID: 26073875 DOI: 10.1164/rccm.201501-0107OC] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
127 van de Vosse E, van Ostaijen-Ten Dam MM, Vermaire R, Verhard EM, Waaijer JL, Bakker JA, Bernards ST, Eibel H, van Tol MJ, van Dissel JT, Haverkamp MH. Recurrent respiratory tract infections (RRTI) in the elderly: A late onset mild immunodeficiency? Clin Immunol 2017;180:111-9. [PMID: 28487087 DOI: 10.1016/j.clim.2017.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
128 Levesque MC, St. Clair EW. B cell–directed therapies for autoimmune disease and correlates of disease response and relapse. Journal of Allergy and Clinical Immunology 2008;121:13-21. [DOI: 10.1016/j.jaci.2007.11.030] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
129 Stohl W. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2014;18:473-89. [DOI: 10.1517/14728222.2014.888415] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
130 Wu MY, Chen CS, Yiang GT, Cheng PW, Chen YL, Chiu HC, Liu KH, Lee WC, Li CJ. The Emerging Role of Pathogenesis of IgA Nephropathy. J Clin Med 2018;7:E225. [PMID: 30127305 DOI: 10.3390/jcm7080225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
131 Salzer U, Grimbacher B. Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation? Curr Opin Rheumatol. 2006;18:377-382. [PMID: 16763458 DOI: 10.1097/01.bor.0000231906.12172.6e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
132 Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 2007;109:2961-7. [PMID: 17119122 DOI: 10.1182/blood-2006-08-041772] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
133 Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9:491-502. [PMID: 19521398 DOI: 10.1038/nri2572] [Cited by in Crossref: 593] [Cited by in F6Publishing: 530] [Article Influence: 49.4] [Reference Citation Analysis]
134 Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood 2006;108:2687-94. [PMID: 16825497 DOI: 10.1182/blood-2005-12-017319] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
135 Hoek KL, Carlesso G, Clark ES, Khan WN. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling. J Immunol 2009;183:5630-43. [PMID: 19843948 DOI: 10.4049/jimmunol.0901100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
136 Deane S, Selmi C, Naguwa SM, Teuber SS, Gershwin ME. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol 2009;150:311-24. [PMID: 19571563 DOI: 10.1159/000226232] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
137 Lehnhardt A, Dunst F, van Husen M, Loos S, Oh J, Eiermann T, Koch M, Kemper MJ. Elevated serum levels of B-cell activating factor in pediatric renal transplant patients. Pediatr Nephrol 2012;27:1389-95. [DOI: 10.1007/s00467-012-2142-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
138 Benson MJ, Dillon SR, Castigli E, Geha RS, Xu S, Lam KP, Noelle RJ. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008;180:3655-9. [PMID: 18322170 DOI: 10.4049/jimmunol.180.6.3655] [Cited by in Crossref: 311] [Cited by in F6Publishing: 282] [Article Influence: 23.9] [Reference Citation Analysis]
139 Li K, Yu W, Cao R, Zhu Z, Zhao G. Microglia-mediated BAFF–BAFFR ligation promotes neuronal survival in brain ischemia injury. Neuroscience 2017;363:87-96. [DOI: 10.1016/j.neuroscience.2017.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
140 Prieto-Peña D, Genre F, Remuzgo-Martínez S, Pulito-Cueto V, Atienza-Mateo B, Llorca J, Sevilla-Pérez B, Ortego-Centeno N, Lera-Gómez L, Leonardo MT, Peñalba A, Narváez J, Martín-Penagos L, Rodrigo E, Miranda-Filloy JA, Caminal-Montero L, Collado P, Pérez JS, de Argila D, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Agirregoikoa E, Gualillo O, Martín J, Castañeda S, Blanco R, González-Gay MA, López-Mejías R. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis. Sci Rep 2021;11:11510. [PMID: 34075170 DOI: 10.1038/s41598-021-91055-z] [Reference Citation Analysis]
141 Sakai J, Akkoyunlu M. The Role of BAFF System Molecules in Host Response to Pathogens. Clin Microbiol Rev 2017;30:991-1014. [PMID: 28855265 DOI: 10.1128/CMR.00046-17] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 8.8] [Reference Citation Analysis]
142 Sutherland AP, Mackay F, Mackay CR. Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas. Pharmacology & Therapeutics 2006;112:774-86. [DOI: 10.1016/j.pharmthera.2006.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
143 Losi CG, Silini A, Fiorini C, Soresina A, Meini A, Ferrari S, Notarangelo LD, Lougaris V, Plebani A. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 2005;25:496-502. [PMID: 16160919 DOI: 10.1007/s10875-005-5637-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
144 Celada LJ, Drake WP. Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy? Immunotherapy 2015;7:57-66. [PMID: 25572480 DOI: 10.2217/imt.14.103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
145 Zhang P, Liu X, Guo A, Xiong J, Fu Y, Zou K. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci 2016;61:2608-18. [DOI: 10.1007/s10620-016-4136-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
146 Karnell JL, Ettinger R. The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory. Front Immunol 2012;3:2. [PMID: 22566888 DOI: 10.3389/fimmu.2012.00002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
147 Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, Kalled SL, Scott ML. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004;173:2331-41. [PMID: 15294946 DOI: 10.4049/jimmunol.173.4.2331] [Cited by in Crossref: 189] [Cited by in F6Publishing: 175] [Article Influence: 11.1] [Reference Citation Analysis]
148 Kim YH, Choi BH, Cheon HG, Do MS. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009;41:208-16. [PMID: 19293640 DOI: 10.3858/emm.2009.41.3.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
149 Tsuji-Kawahara S, Chikaishi T, Takeda E, Kato M, Kinoshita S, Kajiwara E, Takamura S, Miyazawa M. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. J Virol 2010;84:6082-95. [PMID: 20375169 DOI: 10.1128/JVI.02516-09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
150 Henley T, Kovesdi D, Turner M. B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta. Eur J Immunol 2008;38:3543-8. [PMID: 19016531 DOI: 10.1002/eji.200838618] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
151 Vugmeyster Y, Seshasayee D, Chang W, Storn A, Howell K, Sa S, Nelson T, Martin F, Grewal I, Gilkerson E. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Am J Pathol. 2006;168:476-489. [PMID: 16436662 DOI: 10.2353/ajpath.2006.050600] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
152 Huntington ND, Xu Y, Puthalakath H, Light A, Willis SN, Strasser A, Tarlinton DM. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat Immunol 2006;7:190-8. [DOI: 10.1038/ni1292] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
153 Chang Y, Jia X, Sun X, Xu S, Wu Y, Zhang L, Wei W. APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis. Molecular Immunology 2015;64:90-8. [DOI: 10.1016/j.molimm.2014.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
154 Bader L, Koldingsnes W, Nossent J. B-lymphocyte activating factor levels are increased in patients with Wegener's granulomatosis and inversely correlated with ANCA titer. Clin Rheumatol 2010;29:1031-5. [PMID: 20582728 DOI: 10.1007/s10067-010-1526-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
155 Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8. [PMID: 15701725 DOI: 10.1182/blood-2004-11-4284] [Cited by in Crossref: 405] [Cited by in F6Publishing: 366] [Article Influence: 25.3] [Reference Citation Analysis]
156 Coquery CM, Wade NS, Loo WM, Kinchen JM, Cox KM, Jiang C, Tung KS, Erickson LD. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice. PLoS One 2014;9:e102284. [PMID: 25010693 DOI: 10.1371/journal.pone.0102284] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
157 Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells. Diabetes 2009;58:1568-77. [PMID: 19336675 DOI: 10.2337/db08-1504] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
158 Vidal-Laliena M, Romero X, March S, Requena V, Petriz J, Engel P. Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol 2005;236:6-16. [PMID: 16157322 DOI: 10.1016/j.cellimm.2005.08.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.0] [Reference Citation Analysis]
159 Kampa M, Notas G, Stathopoulos EN, Tsapis A, Castanas E. The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer. Front Oncol 2020;10:827. [PMID: 32612943 DOI: 10.3389/fonc.2020.00827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
160 Woo YJ, Yoon BY, Jhun JY, Oh HJ, Min SW, Cho ML, Park SH, Kim HY, Min JK. Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cells. Exp Mol Med 2011;43:350-7. [PMID: 21515993 DOI: 10.3858/emm.2011.43.6.038] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
161 Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007;56:1134-44. [PMID: 17393395 DOI: 10.1002/art.22458] [Cited by in Crossref: 153] [Cited by in F6Publishing: 125] [Article Influence: 10.9] [Reference Citation Analysis]
162 Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol. 2009;158:155-163. [PMID: 19737141 DOI: 10.1111/j.1365-2249.2009.04007.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 97] [Article Influence: 9.4] [Reference Citation Analysis]
163 Coquery CM, Loo WM, Wade NS, Bederman AG, Tung KS, Lewis JE, Hess H, Erickson LD. BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity. Arthritis Rheumatol 2015;67:773-84. [PMID: 25385309 DOI: 10.1002/art.38950] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
164 Cerutti A, Chen K. Role of BAFF and APRIL in Antibody Production and Diversification. In: Cancro MP, editor. BLyS Ligands and Receptors. Totowa: Humana Press; 2010. pp. 65-92. [DOI: 10.1007/978-1-60327-013-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
165 Chhabra M, Conlon TM, Saeb-parsy K, Pettigrew GJ. BAFF and Associated TNF Superfamily Members in Renal Transplantation: An End to BLySful Ignorance. Transplantation 2013;96:853-9. [DOI: 10.1097/tp.0b013e3182997d34] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
166 Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, Qiang F, Gorelik L, Kalled SL, Acha-Orbea H, Rennert PD, Tschopp J, Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 2005;201:1375-83. [PMID: 15851487 DOI: 10.1084/jem.20042309] [Cited by in Crossref: 250] [Cited by in F6Publishing: 218] [Article Influence: 15.6] [Reference Citation Analysis]
167 Gardam S, Brink R. Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol 2014;4:509. [PMID: 24432023 DOI: 10.3389/fimmu.2013.00509] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
168 Stohl W. Editorial: The BAFFling Immunology of Systemic Lupus Erythematosus: Beyond B Cells: Editorial. Arthritis & Rheumatology 2015;67:612-5. [DOI: 10.1002/art.38951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
169 Kaur K, Chowdhury S, Greenspan NS, Schreiber JR. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007;110:2948-54. [PMID: 17634409 DOI: 10.1182/blood-2007-01-069245] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
170 Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 2006;18:263-75. [PMID: 16914324 DOI: 10.1016/j.smim.2006.04.006] [Cited by in Crossref: 331] [Cited by in F6Publishing: 267] [Article Influence: 22.1] [Reference Citation Analysis]
171 Chen M, Lin X, Liu Y, Li Q, Deng Y, Liu Z, Brand D, Guo Z, He X, Ryffel B, Zheng SG. The function of BAFF on T helper cells in autoimmunity. Cytokine Growth Factor Rev 2014;25:301-5. [PMID: 24411564 DOI: 10.1016/j.cytogfr.2013.12.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
172 Zhang H, Wang S, Su X, Fu Q, Li J, Wang J, Deng R, Wu C, Huang Q, Liu L, Wang C. The role of soluble B cell-activating factor in further stratifying the risk of antibody-mediated rejection post-renal transplant: A meta-analysis. Int Immunopharmacol 2020;79:106059. [PMID: 31865240 DOI: 10.1016/j.intimp.2019.106059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
173 Seckinger A, Delgado JA, Moser S, Moreno L, Neuber B, Grab A, Lipp S, Merino J, Prosper F, Emde M, Delon C, Latzko M, Gianotti R, Lüoend R, Murr R, Hosse RJ, Harnisch LJ, Bacac M, Fauti T, Klein C, Zabaleta A, Hillengass J, Cavalcanti-Adam EA, Ho AD, Hundemer M, San Miguel JF, Strein K, Umaña P, Hose D, Paiva B, Vu MD. Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment. Cancer Cell 2017;31:396-410. [PMID: 28262554 DOI: 10.1016/j.ccell.2017.02.002] [Cited by in Crossref: 146] [Cited by in F6Publishing: 121] [Article Influence: 36.5] [Reference Citation Analysis]
174 Ai H, Shen Y, Min C, Pang S, Zhang J, Zhang S, Zhao Z. Molecular structure, expression and bioactivity characterization of TNF13B (BAFF) gene in mefugu, Takifugu obscurus. Fish Shellfish Immunol 2011;30:1265-74. [PMID: 21463693 DOI: 10.1016/j.fsi.2011.03.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
175 Yarchoan M, Ho WJ, Mohan A, Shah Y, Vithayathil T, Leatherman J, Dennison L, Zaidi N, Ganguly S, Woolman S, Cruz K, Armstrong TD, Jaffee EM. Effects of B cell-activating factor on tumor immunity. JCI Insight 2020;5:136417. [PMID: 32434989 DOI: 10.1172/jci.insight.136417] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
176 Lin WY, Gong Q, Seshasayee D, Lin Z, Ou Q, Ye S, Suto E, Shu J, Lee WP, Lee CW, Fuh G, Leabman M, Iyer S, Howell K, Gelzleichter T, Beyer J, Danilenko D, Yeh S, DeForge LE, Ebens A, Thompson JS, Ambrose C, Balazs M, Starovasnik MA, Martin F. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade. Blood 2007;110:3959-67. [PMID: 17687108 DOI: 10.1182/blood-2007-04-088088] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
177 Bojadzic D, Buchwald P. Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions. Curr Top Med Chem 2018;18:674-99. [PMID: 29848279 DOI: 10.2174/1568026618666180531092503] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
178 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 Deng BP, Zhang Y, Wang QJ, Xu XF, Zhang H, Yang YM, Mao HT, Gao WJ, Song BF, Kong BH, Qu X. Soluble BAFF-R produced by decidual stromal cells plays an inhibitory role in monocytes and macrophages. Reprod Biomed Online 2012;24:654-63. [PMID: 22503273 DOI: 10.1016/j.rbmo.2012.02.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
180 Salazar-Camarena DC, Ortíz-Lazareno P, Marín-Rosales M, Cruz A, Muñoz-Valle F, Tapia-Llanos R, Orozco-Barocio G, Machado-Contreras R, Palafox-Sánchez CA. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus. Cytokine 2019;114:115-27. [PMID: 30467093 DOI: 10.1016/j.cyto.2018.11.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
181 Lisak RP, Ragheb S. The role of B cell-activating factor in autoimmune myasthenia gravis: BAFF in myasthenia gravis. Annals of the New York Academy of Sciences 2012;1274:60-7. [DOI: 10.1111/j.1749-6632.2012.06842.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
182 Comarmond C, Garrido M, Pol S, Desbois AC, Costopoulos M, Le Garff-Tavernier M, Si Ahmed SN, Alric L, Fontaine H, Bellier B, Maciejewski A, Rosenzwajg M, Klatzmann D, Musset L, Poynard T, Cacoub P, Saadoun D. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis. Gastroenterology 2017;152:2052-2062.e2. [PMID: 28274850 DOI: 10.1053/j.gastro.2017.02.037] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
183 Mackay F, Groom JR, Tangye SG. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome. Current Opinion in Rheumatology 2007;19:406-13. [DOI: 10.1097/bor.0b013e328277ef4c] [Cited by in Crossref: 42] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
184 Bosello S, Pers J, Rochas C, Devauchelle V, De Santis M, Daridon C, Saraux A, Ferraccioli G, Youinou P. Baff and Rheumatic Autoimmune Disorders: Implications for Disease Management and Therapy. Int J Immunopathol Pharmacol 2007;20:1-8. [DOI: 10.1177/039463200702000101] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
185 Chtanova T, Newton R, Liu SM, Weininger L, Young TR, Silva DG, Bertoni F, Rinaldi A, Chappaz S, Sallusto F, Rolph MS, Mackay CR. Identification of T cell-restricted genes, and signatures for different T cell responses, using a comprehensive collection of microarray datasets. J Immunol 2005;175:7837-47. [PMID: 16339519 DOI: 10.4049/jimmunol.175.12.7837] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
186 Stohl W, Hilbert DM. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol 2012;30:69-77. [PMID: 22231104 DOI: 10.1038/nbt.2076] [Cited by in Crossref: 91] [Cited by in F6Publishing: 254] [Article Influence: 10.1] [Reference Citation Analysis]
187 De Riva A, Wållberg M, Ronchi F, Coulson R, Sage A, Thorne L, Goodfellow I, McCoy KD, Azuma M, Cooke A, Busch R. Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment. PLoS One 2017;12:e0181964. [PMID: 28771521 DOI: 10.1371/journal.pone.0181964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
188 Gupta M, Dillon SR, Ziesmer SC, Feldman AL, Witzig TE, Ansell SM, Cerhan JR, Novak AJ. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood 2009;113:5206-16. [PMID: 19321861 DOI: 10.1182/blood-2008-09-179762] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
189 Yang L, Zhou L, Zong X, Cao X, Ji X, Gu W, Zhang S. Characterization of the molecular structure, expression and bioactivity of the TNFSF13B (BAFF) gene of the South African clawed frog, Xenopus laevis. Int Immunopharmacol 2013;15:478-87. [PMID: 23428910 DOI: 10.1016/j.intimp.2013.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
190 Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 2007;66:790-7. [PMID: 17185325 DOI: 10.1136/ard.2006.065656] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
191 Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2020;24:1135-45. [PMID: 32900236 DOI: 10.1080/14728222.2020.1821647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
192 Carrillo-Ballesteros FJ, Palafox-Sánchez CA, Franco-Topete RA, Muñoz-Valle JF, Orozco-Barocio G, Martínez-Bonilla GE, Gómez-López CE, Marín-Rosales M, López-Villalobos EF, Luquin S, Castañeda-Chávez A, Oregon-Romero E. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures. Clin Exp Med 2020;20:615-26. [PMID: 32506205 DOI: 10.1007/s10238-020-00637-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
193 Sevdali E, Block Saldana V, Speletas M, Eibel H. BAFF receptor polymorphisms and deficiency in humans. Curr Opin Immunol 2021;71:103-10. [PMID: 34311146 DOI: 10.1016/j.coi.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Adem J, Eray M, Eeva J, Nuutinen U, Pelkonen J. Advantages of targeting B cell receptor complex to treat B-cell derived autoimmune diseases and lymphomas. Mol Immunol 2017;88:135-7. [PMID: 28644972 DOI: 10.1016/j.molimm.2017.05.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
195 Bonilla FA, Geha RS. Common Variable Immunodeficiency. Pediatr Res 2009;65:13R-9R. [DOI: 10.1203/pdr.0b013e31819dbf88] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
196 Frasca D, Riley RL, Blomberg BB. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF. Exp Gerontol 2007;42:192-203. [PMID: 17067770 DOI: 10.1016/j.exger.2006.09.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
197 Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol. 2005;17:282-289. [PMID: 15886118 DOI: 10.1016/j.coi.2005.04.005] [Cited by in Crossref: 251] [Cited by in F6Publishing: 220] [Article Influence: 15.7] [Reference Citation Analysis]
198 Shinners NP, Carlesso G, Castro I, Hoek KL, Corn RA, Woodland RL, Scott ML, Wang D, Khan WN. Bruton’s Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family. J Immunol 2007;179:3872-80. [DOI: 10.4049/jimmunol.179.6.3872] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
199 Baker D, Pryce G, James LK, Schmierer K, Giovannoni G. Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis. Eur J Neurol 2019;27:221-8. [DOI: 10.1111/ene.14105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
200 Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, Youinou P. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005;1050:34-39. [PMID: 16014518 DOI: 10.1196/annals.1313.004] [Cited by in Crossref: 243] [Cited by in F6Publishing: 203] [Article Influence: 15.2] [Reference Citation Analysis]
201 Kang S, Fedoriw Y, Brenneman EK, Truong YK, Kikly K, Vilen BJ. BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis. J Immunol 2017;198:2602-11. [PMID: 28235864 DOI: 10.4049/jimmunol.1600281] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
202 Wheway J, Mackay CR, Newton RA, Sainsbury A, Boey D, Herzog H, Mackay F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med. 2005;202:1527-1538. [PMID: 16330815 DOI: 10.1084/jem.20051971] [Cited by in Crossref: 130] [Cited by in F6Publishing: 114] [Article Influence: 8.7] [Reference Citation Analysis]
203 Yang M, Hase H, Legarda-Addison D, Varughese L, Seed B, Ting AT. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 2005;175:2814-24. [PMID: 16116167 DOI: 10.4049/jimmunol.175.5.2814] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 5.4] [Reference Citation Analysis]
204 Wu HT, Yan XM, Hu YL, Diao ZY, Wu J, Zhang SQ. Expression, characterization of recombinant human soluble BAFF secreted from CHO cell. Mol Biol 2009;43:76-81. [DOI: 10.1134/s0026893309010105] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Groom J, Mackay F. B cells flying solo. Immunol Cell Biol 2008;86:40-6. [PMID: 18172443 DOI: 10.1038/sj.icb.7100142] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
206 Ritter C, Förster D, Albrecht P, Hartung HP, Kieseier BC, Lehmann HC. IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuroimmunol 2014;274:225-9. [PMID: 25002077 DOI: 10.1016/j.jneuroim.2014.06.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
207 Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity?: New genetic defects in common variable immunodeficiency. Current Opinion in Allergy & Clinical Immunology 2005;5:496-503. [DOI: 10.1097/01.all.0000191887.89773.cc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
208 Khan WN, Shinners NP, Castro I, Hoek KL. BAFF Receptor Regulation of Peripheral B-Lymphocyte Survival and Development. In: Cancro MP, editor. BLyS Ligands and Receptors. Totowa: Humana Press; 2010. pp. 19-41. [DOI: 10.1007/978-1-60327-013-7_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
209 Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol 2006;18:290-6. [PMID: 16931038 DOI: 10.1016/j.smim.2006.06.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
210 Qin Q, Chang Y, Wang D, Wu Y, Zhang L, Wei W. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis. International Immunopharmacology 2011;11:2167-75. [DOI: 10.1016/j.intimp.2011.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
211 Woodland RT, Schmidt MR, Thompson CB. BLyS and B cell homeostasis. Semin Immunol 2006;18:318-26. [PMID: 16931037 DOI: 10.1016/j.smim.2006.06.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
212 Kanagavelu S, Termini JM, Gupta S, Raffa FN, Fuller KA, Rivas Y, Philip S, Kornbluth RS, Stone GW. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS One 2014;9:e90100. [PMID: 24587225 DOI: 10.1371/journal.pone.0090100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
213 Salzer U, Bacchelli C, Buckridge S, Pan-Hammarström Q, Jennings S, Lougaris V, Bergbreiter A, Hagena T, Birmelin J, Plebani A, Webster AD, Peter HH, Suez D, Chapel H, McLean-Tooke A, Spickett GP, Anover-Sombke S, Ochs HD, Urschel S, Belohradsky BH, Ugrinovic S, Kumararatne DS, Lawrence TC, Holm AM, Franco JL, Schulze I, Schneider P, Gertz EM, Schäffer AA, Hammarström L, Thrasher AJ, Gaspar HB, Grimbacher B. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009;113:1967-76. [PMID: 18981294 DOI: 10.1182/blood-2008-02-141937] [Cited by in F6Publishing: 151] [Reference Citation Analysis]
214 Reyes LI, León F, González P, Rozas MF, Labarca C, Segovia A, Neira O, Naves R. Dexamethasone inhibits BAFF expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Cytokine 2008;42:170-8. [PMID: 18316202 DOI: 10.1016/j.cyto.2007.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
215 Zhao Y, Sun X, Yang X, Zhang B, Li S, Han P, Zhang B, Wang X, Li S, Chang Y, Wei W. Tolerogenic Dendritic Cells Generated by BAFF Silencing Ameliorate Collagen-Induced Arthritis by Modulating the Th17/Regulatory T Cell Balance. J Immunol 2020;204:518-30. [PMID: 31843958 DOI: 10.4049/jimmunol.1900552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
216 Liberal R, de Boer YS, Heneghan MA. Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2021;6:315-26. [DOI: 10.1016/s2468-1253(20)30328-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Gavin AL, Duong B, Skog P, Aït-azzouzene D, Greaves DR, Scott ML, Nemazee D. ΔBAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models. J Immunol 2005;175:319-28. [DOI: 10.4049/jimmunol.175.1.319] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 5.2] [Reference Citation Analysis]
218 Myles A, Cancro MP. The NIK of time for B cells. Eur J Immunol 2016;46:547-51. [PMID: 26873522 DOI: 10.1002/eji.201646294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
219 Granja AG, Tafalla C. Different IgM+ B cell subpopulations residing within the peritoneal cavity of vaccinated rainbow trout are differently regulated by BAFF. Fish Shellfish Immunol 2019;85:9-17. [PMID: 28989090 DOI: 10.1016/j.fsi.2017.10.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
220 Thorn M, Lewis RH, Mumbey-Wafula A, Kantrowitz S, Spatz LA. BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion. Cell Immunol 2010;261:9-22. [PMID: 19914608 DOI: 10.1016/j.cellimm.2009.10.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
221 Thaler FS, Laurent SA, Huber M, Mulazzani M, Dreyling M, Ködel U, Kümpfel T, Straube A, Meinl E, von Baumgarten L. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma. Neuro Oncol 2017;19:1618-27. [PMID: 28521029 DOI: 10.1093/neuonc/nox097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
222 Mikkilineni L, Kochenderfer JN. CAR T cell therapies for patients with multiple myeloma. Nat Rev Clin Oncol 2021;18:71-84. [PMID: 32978608 DOI: 10.1038/s41571-020-0427-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 26.0] [Reference Citation Analysis]
223 Kim MY, Kim DH, Do MS. B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages. Exp Mol Med 2013;45:e4. [PMID: 23306702 DOI: 10.1038/emm.2013.4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
224 Nagatani K, Itoh K, Nakajima K, Kuroki H, Katsuragawa Y, Mochizuki M, Aotsuka S, Mimori A. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 2007;56:3554-63. [PMID: 17968879 DOI: 10.1002/art.22929] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
225 Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Mariño E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST. Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol 2009;182:793-801. [PMID: 19124722 DOI: 10.4049/jimmunol.182.2.793] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
226 Min YN, Wang CY, Li XX, Hou Y, Qiu JH, Ma J, Shao LL, Zhang X, Wang YW, Peng J. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia. J Thromb Haemost. 2016;14:559-571. [PMID: 26749059 DOI: 10.1111/jth.13246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
227 Aït-Azzouzene D, Gavin AL, Skog P, Duong B, Nemazee D. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen. Eur J Immunol 2006;36:985-96. [PMID: 16511898 DOI: 10.1002/eji.200535581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
228 Papadas A, Asimakopoulos F. Mechanisms of Resistance in Multiple Myeloma. In: Mandalà M, Romano E, editors. Mechanisms of Drug Resistance in Cancer Therapy. Cham: Springer International Publishing; 2018. pp. 251-88. [DOI: 10.1007/164_2017_10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
229 Zhu X, Shi Y, Zhang F, Yao Q, Liu Y, Shan N, Wang D, Peng J, Xu J, Hou M. Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia. Br J Haematol 2014;166:783-91. [DOI: 10.1111/bjh.12958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
230 Ding S, Mao X, Cao Y, Wang N, Xu H, Zhou J. Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas. Target Oncol 2020;15:365-75. [PMID: 32495161 DOI: 10.1007/s11523-020-00729-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
231 Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Control systems and decision making for antibody production. Nat Immunol. 2010;11:681-688. [PMID: 20644574 DOI: 10.1038/ni.1900] [Cited by in Crossref: 291] [Cited by in F6Publishing: 251] [Article Influence: 26.5] [Reference Citation Analysis]
232 Wei F, Xu S, Jia X, Sun X, Yang X, Wei W, Chang Y. BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats. International Immunopharmacology 2016;31:1-8. [DOI: 10.1016/j.intimp.2015.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
233 Colvin MM, Cook JL, Chang PP, Hsu DT, Kiernan MS, Kobashigawa JA, Lindenfeld J, Masri SC, Miller DV, Rodriguez ER, Tyan DB, Zeevi A; On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia. Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. Circulation 2019;139. [DOI: 10.1161/cir.0000000000000598] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 15.5] [Reference Citation Analysis]
234 Sun CY, Shen Y, Chen XW, Yan YC, Wu FX, Dai M, Li T, Yang CD. The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression. Int J Rheumatol 2013;2013:954292. [PMID: 23843794 DOI: 10.1155/2013/954292] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
235 Ohmatsu H, Sugaya M, Miyagaki T, Suga H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma: BAFF levels are increased in patients with CTCL. British Journal of Dermatology 2012;167:359-67. [DOI: 10.1111/j.1365-2133.2012.10998.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
236 Gorbacheva V, Ayasoufi K, Fan R, Baldwin WM 3rd, Valujskikh A. B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells. Am J Transplant 2015;15:346-57. [PMID: 25496308 DOI: 10.1111/ajt.12984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
237 Dong W, Zhu P, Wang Y, Wang Z. Follicular helper T cells in systemic lupus erythematosus: A potential therapeutic target. Autoimmunity Reviews 2011;10:299-304. [DOI: 10.1016/j.autrev.2010.11.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
238 Peng HL, Zhang Y, Sun NN, Yin YF, Wang YW, Cheng Z, Yan WZ, Liu SF, Xu YX, Xiao X, Zhang GS. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia. J Thromb Haemost 2017;15:2259-69. [PMID: 28834165 DOI: 10.1111/jth.13806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
239 Bracewell C, Isaacs J, Emery P, Ng W. Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 2009;9:909-19. [DOI: 10.1517/14712590903033919] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
240 Bossen C, Cachero TG, Tardivel A, Ingold K, Willen L, Dobles M, Scott ML, Maquelin A, Belnoue E, Siegrist CA, Chevrier S, Acha-Orbea H, Leung H, Mackay F, Tschopp J, Schneider P. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 2008;111:1004-12. [PMID: 17942754 DOI: 10.1182/blood-2007-09-110874] [Cited by in Crossref: 207] [Cited by in F6Publishing: 190] [Article Influence: 14.8] [Reference Citation Analysis]
241 Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008;74:261-71. [PMID: 18561200 DOI: 10.1002/cyto.b.20432] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
242 Byng-Maddick R, Ehrenstein MR. The impact of biological therapy on regulatory T cells in rheumatoid arthritis. Rheumatology (Oxford) 2015;54:768-75. [PMID: 25667434 DOI: 10.1093/rheumatology/keu487] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
243 Kimberley FC, van Bostelen L, Cameron K, Hardenberg G, Marquart JA, Hahne M, Medema JP. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J 2009;23:1584-95. [PMID: 19141538 DOI: 10.1096/fj.08-124669] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
244 Koarada S, Tada Y, Sohma Y, Haruta Y, Suematsu R, Mitamura M, Inoue H, Ehara H, Tokoro Y, Ohta A. Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects. Rheumatology (Oxford). 2010;49:662-670. [PMID: 20097906 DOI: 10.1093/rheumatology/kep437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
245 Coquery CM, Erickson LD. Regulatory roles of the tumor necrosis factor receptor BCMA. Crit Rev Immunol 2012;32:287-305. [PMID: 23237506 DOI: 10.1615/critrevimmunol.v32.i4.10] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
246 La Cava A. Anticytokine therapies in systemic lupus erythematosus. Immunotherapy 2010;2:575-82. [PMID: 20636010 DOI: 10.2217/imt.10.29] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
247 Levesque MC. Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol 2009;157:198-208. [PMID: 19604259 DOI: 10.1111/j.1365-2249.2009.03979.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
248 Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann Rheum Dis 2007;66:700-3. [PMID: 17040963 DOI: 10.1136/ard.2006.060772] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 7.6] [Reference Citation Analysis]
249 Deng B, Liu X, Li X, Zhang X, Quan C, Chen X. Raised cerebrospinal fluid BAFF and APRIL levels in anti- N -methyl- d -aspartate receptor encephalitis: Correlation with clinical outcome. Journal of Neuroimmunology 2017;305:84-91. [DOI: 10.1016/j.jneuroim.2017.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
250 Ando M, Goto A, Takeno Y, Yamasue M, Komiya K, Umeki K, Nureki SI, Miyazaki E, Kadota JI. Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis. Clin Rheumatol 2018;37:2833-8. [PMID: 29936689 DOI: 10.1007/s10067-018-4183-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
251 Dechkhajorn W, Benjathummarak S, Glaharn S, Chaisri U, Viriyavejakul P, Maneerat Y. The activation of BAFF/APRIL system in spleen and lymph nodes of Plasmodium falciparum infected patients. Sci Rep 2020;10:3865. [PMID: 32123265 DOI: 10.1038/s41598-020-60763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007;204:1959-71. [PMID: 17664289 DOI: 10.1084/jem.20062567] [Cited by in Crossref: 289] [Cited by in F6Publishing: 263] [Article Influence: 20.6] [Reference Citation Analysis]
253 Zhao L, Tyrrell DL. Myeloid dendritic cells can kill T cells during chronic hepatitis C virus infection. Viral Immunol. 2013;26:25-39. [PMID: 23374153 DOI: 10.1089/vim.2012.0058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
254 Zhang X, Park C, Yoon S, Li L, Hsu Y, Ambrose C, Choi YS. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. International Immunology 2005;17:779-88. [DOI: 10.1093/intimm/dxh259] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 6.6] [Reference Citation Analysis]
255 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
256 Ragheb S, Lisak RP. B-cell-activating factor and autoimmune myasthenia gravis. Autoimmune Dis 2011;2011:939520. [PMID: 22235365 DOI: 10.4061/2011/939520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
257 Zhao LD, Li Y, Smith MF Jr, Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus 2010;19:1534-49. [PMID: 20974656 DOI: 10.1177/0961203310375268] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
258 Rodig SJ, Shahsafaei A, Li B, Mackay CR, Dorfman DM. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders. Hum Pathol 2005;36:1113-9. [PMID: 16226112 DOI: 10.1016/j.humpath.2005.08.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
259 Parodis I, Sjöwall C, Jönsen A, Ramsköld D, Zickert A, Frodlund M, Sohrabian A, Arnaud L, Rönnelid J, Malmström V, Bengtsson AA, Gunnarsson I. Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus. Autoimmun Rev 2017;16:343-51. [PMID: 28216072 DOI: 10.1016/j.autrev.2017.02.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
260 Montes C, Acosta-rodríguez E, Mucci J, Zuniga E, Campetella O, Gruppi A. ATrypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol 2006;36:1474-85. [DOI: 10.1002/eji.200535537] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
261 François A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg JE. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res Ther 2013;15:R168. [PMID: 24289101 DOI: 10.1186/ar4352] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 9.5] [Reference Citation Analysis]
262 McManigle W, Youssef A, Sarantopoulos S. B cells in chronic graft-versus-host disease. Hum Immunol 2019;80:393-9. [PMID: 30849450 DOI: 10.1016/j.humimm.2019.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
263 Moura RA, Canhão H, Polido-Pereira J, Rodrigues AM, Navalho M, Mourão AF, Resende C, Campanilho-Marques R, Madruga Dias J, da Silva JA, Graca L, Fonseca JE. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis. J Rheumatol 2013;40:1293-302. [PMID: 23772083 DOI: 10.3899/jrheum.121110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
264 Nakamura N, Hase H, Sakurai D, Yoshida S, Abe M, Tsukada N, Takizawa J, Aoki S, Kojima M, Nakamura S, Kobata T. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody. Virchows Arch 2005;447:53-60. [PMID: 16025281 DOI: 10.1007/s00428-005-1275-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
265 Rolph MS, Young TR, Shum BO, Gorgun CZ, Schmitz-Peiffer C, Ramshaw IA, Hotamisligil GS, Mackay CR. Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol 2006;177:7794-801. [PMID: 17114450 DOI: 10.4049/jimmunol.177.11.7794] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
266 Sazzini M, Zuntini R, Farjadian S, Quinti I, Ricci G, Romeo G, Ferrari S, Calafell F, Luiselli D. An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene. Genes Immun 2009;10:566-78. [DOI: 10.1038/gene.2009.43] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
267 Sharma A, Kiripolsky J, Klimatcheva E, Howell A, Fereidouni F, Levenson R, Rothstein TL, Kramer JM. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction. Clin Immunol 2016;164:85-94. [PMID: 26826598 DOI: 10.1016/j.clim.2016.01.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
268 Rubin SJS, Bloom MS, Robinson WH. B cell checkpoints in autoimmune rheumatic diseases. Nat Rev Rheumatol 2019;15:303-15. [PMID: 30967621 DOI: 10.1038/s41584-019-0211-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 17.0] [Reference Citation Analysis]
269 Matsushita T, Fujimoto M, Echigo T, Matsushita Y, Shimada Y, Hasegawa M, Takehara K, Sato S. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Experimental Dermatology 2008;17:197-202. [DOI: 10.1111/j.1600-0625.2007.00642.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
270 Lin X, Lu L. B Cell-Mediated Autoimmune Diseases. Adv Exp Med Biol 2020;1254:145-60. [PMID: 32323275 DOI: 10.1007/978-981-15-3532-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
271 Thompson N, Isenberg DA, Jury EC, Ciurtin C. Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome. Rheumatology (Oxford) 2016;55:1548-55. [PMID: 26790457 DOI: 10.1093/rheumatology/kev420] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
272 Tang X, Tong X, An Y. BAFF gene silencing attenuates allergic airway inflammation by promoting the generation of Tregs via activating pro-Treg cytokines. Life Sci 2020;241:117172. [PMID: 31843529 DOI: 10.1016/j.lfs.2019.117172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
273 Zhang F, Shu JL, Li Y, Wu YJ, Zhang XZ, Han L, Tang XY, Wang C, Wang QT, Chen JY, Chang Y, Wu HX, Zhang LL, Wei W. CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents. Front Pharmacol 2017;8:933. [PMID: 29311935 DOI: 10.3389/fphar.2017.00933] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
274 Bassi N, Luisetto R, Ghirardello A, Gatto M, Valente M, Della Barbera M, Nalotto L, Punzi L, Doria A. 17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. Lupus 2015;24:382-91. [PMID: 25801881 DOI: 10.1177/0961203314559636] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
275 Li P, Liu D, Liu Y, Song S, Wang Q, Chang Y, Wu Y, Chen J, Zhao W, Zhang L, Wei W. BAFF/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin. Journal of Ethnopharmacology 2012;141:290-300. [DOI: 10.1016/j.jep.2012.02.034] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
276 Möckel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE). Autoimmun Rev 2021;20:102736. [PMID: 33333233 DOI: 10.1016/j.autrev.2020.102736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
277 Ding H, Wang L, Wu X, Yan J, He Y, Ni B, Gao W, Zhong X. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med 2010;14:1717-25. [PMID: 19627403 DOI: 10.1111/j.1582-4934.2009.00817.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
278 So T, Lee S, Croft M. Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity. International Journal of Hematology 2006;83:1-11. [DOI: 10.1532/ijh97.05120] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
279 Miao R, Ding B, Zhang Y, Xia Q, Li Y, Zhu B. Proteomic profiling change during the early development of silicosis disease. J Thorac Dis 2016;8:329-41. [PMID: 27076927 DOI: 10.21037/jtd.2016.02.46] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
280 Yang C, Hou X, Feng Q, Li Y, Wang X, Qin L, Yang P. Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor. J Transl Med 2019;17:426. [PMID: 31864410 DOI: 10.1186/s12967-019-02175-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
281 Yuan H, Wang Y, Wu X, Wang H, Pu J, Ding W, Wang M, Shen X, Cong H, Zhang L, Zhang M, Ju S. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene. DNA Cell Biol 2010;29:133-9. [PMID: 20025535 DOI: 10.1089/dna.2009.0927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
282 Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 2008;105:14993-8. [PMID: 18820032 DOI: 10.1073/pnas.0806044105] [Cited by in Crossref: 148] [Cited by in F6Publishing: 140] [Article Influence: 11.4] [Reference Citation Analysis]
283 Khan WN, Wright JA, Kleiman E, Boucher JC, Castro I, Clark ES. B-lymphocyte tolerance and effector function in immunity and autoimmunity. Immunol Res 2013;57:335-53. [DOI: 10.1007/s12026-013-8466-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
284 Fairfax K, Mackay IR, Mackay F. BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus. IUBMB Life 2012;64:595-602. [PMID: 22641424 DOI: 10.1002/iub.1046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
285 Kang SY, Kang CH, Lee KH. B-cell-activating factor is elevated in serum of patients with myasthenia gravis. Muscle Nerve 2016;54:1030-3. [PMID: 27121160 DOI: 10.1002/mus.25162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
286 Hasler P, Zouali M. B lymphocytes as therapeutic targets in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2006;10:803-15. [DOI: 10.1517/14728222.10.6.803] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
287 Toubi E, Gordon S, Kessel A, Rosner I, Rozenbaum M, Shoenfeld Y, Zuckerman E. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 2006;27:134-9. [PMID: 17029886 DOI: 10.1016/j.jaut.2006.07.005] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
288 Darce JR, Arendt BK, Chang SK, Jelinek DF. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J Immunol 2007;178:5612-22. [PMID: 17442944 DOI: 10.4049/jimmunol.178.9.5612] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
289 Jia X, Wei F, Sun X, Chang Y, Xu S, Yang X, Wang C, Wei W. CP-25 attenuates the inflammatory response of fibroblast-like synoviocytes co-cultured with BAFF-activated CD4+ T cells. Journal of Ethnopharmacology 2016;189:194-201. [DOI: 10.1016/j.jep.2016.05.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
290 Bornacelly A, Mercado D, Acevedo N, Caraballo L. The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF). BMC Immunol 2014;15:22. [PMID: 24906685 DOI: 10.1186/1471-2172-15-22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
291 Yang S, Li JY, Xu W. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma. Crit Rev Oncol Hematol 2014;91:113-22. [PMID: 24629840 DOI: 10.1016/j.critrevonc.2014.02.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
292 Jacob CO, Yu N, Sindhava V, Cancro MP, Pawar RD, Putterman C, Stohl W. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors: DEVELOPMENT OF SLE IN NZM MICE DEFICIENT IN PAIRS OF BAFF RECEPTORS. Arthritis & Rheumatology 2015;67:2523-35. [DOI: 10.1002/art.39210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
293 Zhou X, Xia Z, Lan Q, Wang J, Su W, Han YP, Fan H, Liu Z, Stohl W, Zheng SG. BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis. PLoS One 2011;6:e23629. [PMID: 21897850 DOI: 10.1371/journal.pone.0023629] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
294 Ehrenstein MR, Wing C. The BAFFling effects of rituximab in lupus: danger ahead? Nat Rev Rheumatol. 2016;12:367-372. [PMID: 26888554 DOI: 10.1038/nrrheum.2016.18] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
295 Ch’en PF, Xu X, Liu X, Liu Y, Song C, Screaton GR, Jin B, Xu X. Characterisation of monoclonal antibodies to the TNF and TNF receptor families. Cellular Immunology 2005;236:78-85. [DOI: 10.1016/j.cellimm.2005.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
296 Rickert RC, Jellusova J, Miletic AV. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 2011;244:115-33. [PMID: 22017435 DOI: 10.1111/j.1600-065X.2011.01067.x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 114] [Article Influence: 21.1] [Reference Citation Analysis]
297 Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5:235-246. [PMID: 16474316 DOI: 10.1038/nrd1982] [Cited by in Crossref: 224] [Cited by in F6Publishing: 192] [Article Influence: 14.9] [Reference Citation Analysis]
298 Hardenberg G, Fernandez L, Hendriks J, Chebli K, Jacquet C, Sitbon M, Hahne M, Medema JP. APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. J Leukoc Biol 2008;84:380-8. [PMID: 18483203 DOI: 10.1189/jlb.1207853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
299 Wang ZZ, Song J, Wang H, Li JX, Xiao Q, Yu Z, Liu JX, Liu Z. B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps. Front Immunol 2020;11:625630. [PMID: 33552090 DOI: 10.3389/fimmu.2020.625630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Liu K, Zhang Y, Hu S, Yu Y, Yang Q, Jin D, Chen X, Jin Q, Liu H. Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis. PLoS One 2012;7:e38429. [PMID: 22719887 DOI: 10.1371/journal.pone.0038429] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
301 Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol 2011;32:388-94. [PMID: 21752714 DOI: 10.1016/j.it.2011.06.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 11.1] [Reference Citation Analysis]
302 Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN. B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res 2013;19:2048-60. [PMID: 23344265 DOI: 10.1158/1078-0432.CCR-12-2422] [Cited by in Crossref: 308] [Cited by in F6Publishing: 198] [Article Influence: 38.5] [Reference Citation Analysis]
303 Sun Y, Sun L. CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity. PLoS One 2015;10:e0136015. [PMID: 26295165 DOI: 10.1371/journal.pone.0136015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
304 Zollars E, Bienkowska J, Czerkowicz J, Allaire N, Ranger AM, Magder L, Petri M. BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year. Lupus Sci Med 2015;2:e000063. [PMID: 26113988 DOI: 10.1136/lupus-2014-000063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
305 Ou X, Xu S, Lam KP. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival. Proc Natl Acad Sci U S A 2012;109:15401-6. [PMID: 22949644 DOI: 10.1073/pnas.1200386109] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
306 Proust A, Rincé P, Creidy R, Lazure T, Joab I, Garçon L, Fabre M, Guettier C, Raphael M. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. Am J Pathol 2011;179:1630-7. [PMID: 21871426 DOI: 10.1016/j.ajpath.2011.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
307 Bloom DD, Reshetylo S, Nytes C, Goodsett CT, Hematti P. Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother 2018;41:213-23. [PMID: 29309290 DOI: 10.1097/CJI.0000000000000209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
308 Wang J, Yang C, Hou X, Xu J, Yun Y, Qin L, Yang P. Rapamycin Modulates the Proinflammatory Memory-Like Response of Microglia Induced by BAFF. Front Immunol 2021;12:639049. [PMID: 34054807 DOI: 10.3389/fimmu.2021.639049] [Reference Citation Analysis]
309 Kalled SL. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 2005;204:43-54. [PMID: 15790349 DOI: 10.1111/j.0105-2896.2005.00219.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 5.7] [Reference Citation Analysis]
310 Natorska J, Marek G, Sadowski J, Undas A. Presence of B cells within aortic valves in patients with aortic stenosis: Relation to severity of the disease. Journal of Cardiology 2016;67:80-5. [DOI: 10.1016/j.jjcc.2015.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
311 Jacob CO, Yu N, Guo S, Jacob N, Quinn WJ 3rd, Sindhava V, Cancro MP, Goilav B, Putterman C, Migone TS, Stohl W. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor. Arthritis Rheum 2013;65:1043-54. [PMID: 23334904 DOI: 10.1002/art.37846] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
312 Chang SK, Mihalcik SA, Jelinek DF. B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation. J Immunol 2008;180:7394-403. [PMID: 18490739 DOI: 10.4049/jimmunol.180.11.7394] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
313 Cho B, Min C, Kim H, Lee S, Kim Y, Lim J, Jeong D, Cho B, Kim H, Eom K, Cho S, Kim D, Lee J, Min W, Kim C, Chung N. High Levels of B Cell Activating Factor During the Peritransplantation Period Are Associated with a Reduced Incidence of Acute Graft-versus-Host Disease following Myeloablative Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2010;16:629-38. [DOI: 10.1016/j.bbmt.2009.11.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
314 Yamamoto Y, Sakisaka T. The emerging role of calcium-modulating cyclophilin ligand in posttranslational insertion of tail-anchored proteins into the endoplasmic reticulum membrane. J Biochem 2015;157:419-29. [PMID: 25869254 DOI: 10.1093/jb/mvv035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
315 Kang JS, Yoon YD, Ahn JH, Kim SC, Kim KH, Kim HM, Moon EY. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 2006;141:181-8. [PMID: 16899986 DOI: 10.1159/000094897] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]